Milestone Pharmaceuticals announces FDA acceptance of response to Cardamyst nasal spray CRL
Milestone also announced the extension of its $75 million Royalty Purchase Agreement with RTW Investments
Milestone also announced the extension of its $75 million Royalty Purchase Agreement with RTW Investments
The agency concluded that for people of all ages, IXCHI should be administered when there is a significant risk of chikungunya infection
Celecoxib is a nonsteroidal anti-inflammatory drug
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
Baxdrostat demonstrated a statistically significant and clinically meaningful reduction of systolic blood pressure compared with placebo
In collaboration with the Gates Foundation, Merck advances MK-8527 pre-exposure prophylaxis (PrEP) clinical trials globally
Spikevax is now approved for all individuals aged 6 months through 64 years at increased risk for COVID-19 disease
Apotex will also pay US$ 2.5 million upon receipt of final USFDA approval of the ANDA that is the subject of the Collaboration Agreement for Paclitaxel Protein-Bound Particles for Injectable Suspension
Havix is a US based company engaged in the business of developing, manufacturing and supplying of various finished formulations
It is intended for contrast enhancement in MRI scans
Subscribe To Our Newsletter & Stay Updated